ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Colorectal Cancer
Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Carcinoma
Ovarian Cancer

Pancreatic Cancer trials near Taipei City, TWN:

MS-20 on Gut Microbiota and Risk/Severity of Cachexia in Pancreatic Cancer Patients

Cachexia has been recognized as a direct cause of reduced quality of life complicating in cancer patients. Patients with pancreatic ...

Enrolling
Pancreatic Cancer
Chemotherapy Effect
Drug: MS-20
Other: Placebo
National Taiwan University
National Taiwan University

Taipei, Taiwan

Antroquinonol is proposed for the treatment of neoplasms. The proposed clinical trial is a Phase I/II study designed to evaluate antroquinon ...

Active, not recruiting
Pancreatic Neoplasm
Drug: Antroquinonol

Phase 1, Phase 2

Golden Biotechnology

Taipei, Taiwan and 8 other locations

Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...

Active, not recruiting
Metastatic Pancreatic Adenocarcinoma
Metastatic Pancreatic Cancer
Drug: nab-paclitaxel
Drug: gemcitabine

Phase 2

Astellas
Astellas

Taipei, Taiwan and 135 other locations

phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...

Enrolling
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Drug: AMG 193
Drug: Gemcitabine

Phase 1

Amgen
Amgen

Taipei, Taiwan and 76 other locations

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-Small Cell Lung Cancer (NSCLC) ...

Enrolling
Gastric/Esophageal Cancer
Micro Satellite Stable Colorectal Cancer
Drug: Bevacizumab
Drug: Azirkitug

Phase 1

AbbVie
AbbVie

Taipei City, Taipei, Taiwan and 34 other locations

to assess the safety, tolerability, PK, PD, immunogenicity and anti-tumor activity of zenocutuzumab (MCLA-128) in patients with solid tumors...

Active, not recruiting
Pancreatic Cancer Harboring NRG1 Fusion
NSCLC Harboring NRG1 Fusion
Drug: zenocutuzumab (MCLA-128)

Phase 2

Partner Therapeutics

Taipei, Taiwan and 63 other locations

This is a study in adults from Asia with different types of advanced cancer (solid tumours). People can join the study if they have cancer...

Enrolling
Gastrointestinal Cancer
Lung Cancer
Drug: BI 765049
Drug: Ezabenlimab

Phase 1

Boehringer Ingelheim
Boehringer Ingelheim

Taipei, Taiwan and 8 other locations

The study drug TRX-920 Oral Gel contains SN38, an active metabolite of Irinotecan (CPT-11), which is a widely prescribed anti-cancer drug th ...

Enrolling
Advanced Solid Tumor
Drug: TRX-920 Oral Gel (10 mg and 30 mg)

Phase 1

TaiRx

Taipei, Taiwan and 2 other locations

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors th...

Active, not recruiting
Breast Cancer
Neuroendocrine Tumors
Drug: Entrectinib

Phase 2

Roche
Roche

Taipei, Taiwan and 129 other locations

to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combinatio...

Enrolling
Advanced Solid Tumor
Non-small Cell Lung Cancer
Drug: Pembrolizumab
Drug: Irinotecan

Phase 1

Lilly
Lilly

Taipei, Taiwan and 57 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems